Loading stock data…
ICON plc (ICLR)
$172.99+3.13 (+1.84%)
After Hours$172.99+0.00 (+0.00%)· Last close Jun 29
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
ICON Public Limited Company in the Healthcare sector is trading at $172.99 with a market capitalization of $11.0B. Wall Street consensus targets $175.31 (16 analysts), implying a +1.3% move over the next 12 months. The stock is currently 18% below its 52-week high of $211.00, remaining 15.9% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Total Revenue | $2.11B↑ | $2.08B↑ | $2.02B↑ | $2.00B↓ | $2.04B |
| Gross Profit | $480.74M↓ | $545.46M↓ | $561.60M↑ | $558.65M↓ | $599.37M |
| Operating Income | $210.75M↓ | $249.38M↓ | $258.88M↓ | $264.31M↓ | $351.26M |
| Net Income | $149.19M↑ | -$284.18M↓ | $182.97M↑ | $154.15M↓ | $260.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, ma...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$11.02B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
49.62
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.23
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
2.20%
Volume
Today's trading volume
1.35M
Recent News
Icon Reestablishes 'Credible' Path to Growth in 2027, RBC Capital Markets Says
Icon (ICLR) has reestablished a "credible" path to mid-single-digit organic growth in 2027 after two
Company News for Jun 25, 2026
Companies in The News Are: KBH, ICLR, WOR, DAL
Here Are Thursday’s Best Wall Street Analyst Research Calls: Brown-Forman, CoreWeave, Intel, JFrog, Keurig Dr. Pepper, Klarna Group, Qualcomm, Shift 4 Payments, and More
Pre-Market Stock Futures: Futures are trading higher this morning, after all the big funds and portfolio managers may have shown their hands on Wednesday, as the tech and chip stocks sell-off resumed after stocks started higher in the morning but faded in the afternoon. The tech sell-off came before Micron Technology (NASDAQ: MU) posted huge ... Here Are Thursday’s Best Wall Street Analyst Research Calls: Brown-Forman, CoreWeave, Intel, JFrog, Keurig Dr. Pepper, Klarna Group, Qualcomm, Shift 4 P
Why Icon Stock Crushed it on Wednesday
The healthcare research specialist unveiled its first set of quarterly figures for 2026.
Icon PLC (ICLR) Q1 2026 Earnings Call Highlights: Strong Bookings and Strategic Expansions Amid ...
Icon PLC (ICLR) reports robust growth in gross bookings and net business wins, while navigating challenges in revenue and margin performance.